Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Cresset Group
Cresset Group
Activities:
Research & Development
Digital
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Research & Development
Cresset aims for global growth with new India headquarters
The company's novel headquarters in Bangalore allows it to service the demands of its APAC customer base
Research & Development
Cresset creates new Vice President role to lead its AI strategy
Dr Mutlu Dogruel joins from Microsoft, where he was responsible for empowering organisations to implement scalable AI solutions into their workflow
Finance
Cresset increases its North America presence with new Boston site
Cresset, a provider of integrated in silico solutions for drug discovery, has expanded its existing North American presence with the creation of a new US facility in Boston
Finance
Cresset announces global collaboration with Enamine
Cresset announces a collaboration with Enamine to develop innovative new solutions for the early drug discovery process
Research & Development
Cresset aims to optimise drug discovery with latest drug design platform release
The software will optimise the determination of potent molecules in silico
Research & Development
Cresset targets international growth with Innovate UK Scaleup Programme
Cresset has been accepted onto the Innovate UK Scaleup Programme, which aims to help specially selected businesses with scaling potential realise their commercial ambitions
Research & Development
Cresset signs alliance to speed up drug design
The alliance between British and Chinese companies is intended to speed up drug design
Subscribe now